Cumberland Pharmaceuticals Inc. Retained Earnings
Cumberland Pharmaceuticals Inc. (CPIX) had Retained Earnings of -$34.37 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-07
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$34.37M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$30.09M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$26.80M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$25.39M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$34.37M 10-Q · filed 2026-08-07 |
| 2026-03-31 | -$30.09M 10-Q · filed 2026-05-08 |
| 2025-12-31 | -$26.80M 10-Q · filed 2026-08-07 |
| 2025-09-30 | -$25.39M 10-Q · filed 2025-11-07 |
| 2025-06-30 | -$23.45M 10-Q · filed 2025-08-08 |
| 2025-03-31 | -$22.71M 10-Q · filed 2025-05-09 |
| 2024-12-31 | -$23.97M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$22.06M 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$20.52M 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$19.43M 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$17.49M 10-K · filed 2025-03-07 |
| 2023-09-30 | -$11.19M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$10.14M 10-Q · filed 2023-08-11 |
| 2023-03-31 | -$11.02M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$11.21M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$8.77M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$8.36M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$7.02M 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$5.64M 10-K · filed 2023-03-13 |
| 2021-09-30 | -$1.79M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$735.63K 10-Q · filed 2021-08-13 |
| 2021-03-31 | -$1.96M 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$2.13M 10-K · filed 2022-03-11 |
| 2020-09-30 | -$1.25M 10-Q · filed 2020-11-13 |
| 2020-06-30 | -$765.50K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $152.78K 10-Q · filed 2020-05-22 |
| 2019-12-31 | $1.21M 10-K · filed 2021-03-12 |
| 2019-09-30 | $2.17M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $4.12M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $4.67M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $4.75M 8-K · filed 2020-12-10 |
| 2018-09-30 | $6.97M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $8.61M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $9.33M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $11.71M 10-K · filed 2019-03-12 |
| 2017-09-30 | $12.51M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $13.25M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $18.41M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $18.60M 10-K · filed 2018-03-09 |
| 2016-09-30 | $19.35M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $19.25M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $19.30M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $19.55M 10-K · filed 2017-03-13 |
| 2015-09-30 | $19.40M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $19.27M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $18.86M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $18.82M 10-K · filed 2016-03-14 |
| 2014-09-30 | $18.15M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $17.40M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $16.68M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $16.39M 10-K · filed 2015-03-09 |
| 2013-09-30 | $17.89M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $18.71M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $19.35M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $18.50M 10-K · filed 2014-03-11 |
| 2012-09-30 | $16.69M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $14.82M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $13.08M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $12.66M 10-K · filed 2013-03-12 |
| 2011-09-30 | $11.74M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $9.90M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $7.00M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |